Health By Olivia Goldhill and Nicholas St. Fleur ‘There absolutely will be a black market’: How the rich and privileged can skip the line for Covid-19 vaccines
First Opinion By Karen Glanz and Holly Fernandez Lynch ‘Three Identical Strangers’: It’s not too late to address the ethical violations
First Opinion By I. Glenn Cohen and Alex Pearlman Creating eggs and sperm from stem cells: the next big thing in assisted reproduction?
First Opinion By Gavin Yamey A coronavirus vaccine should be for everyone, not just those who can afford it
Health By Megan Thielking ‘Traumatic as hell’: Patients describe what it’s like to be restrained in the ER
Health By Ruth Hailu Fitbits and other wearables may not accurately track heart rates in people of color
First Opinion By Peter Kaplan Talent, culture, and ethics are all necessary ingredients in the biotech recipe for success
Health By Nicholas St. Fleur The polio vaccine had Elvis. Can celebrities similarly spur acceptance of the Covid-19 vaccine?
First Opinion By Carleigh Krubiner, Ruth R. Faden, and Ruth A. Karron FDA: Leave the door open to Covid-19 vaccination for pregnant and lactating health workers
First Opinion By Aaron Mitchell and Deborah Korenstein Drug companies’ payments and gifts affect physicians’ prescribing. It’s time to turn off the spigot
First Opinion By Mark Dornauer Frameworks for medical rationing must be created of, for, and with the people
Pharmalot By Ed Silverman Doctors are accepting as much money from industry as they were when OpenPayments launched
First Opinion By Sam Beyda and Abigail Marsh If donating a kidney to a stranger is ethical and allowable, taking part in a Covid-19 challenge trial should be, too
First Opinion By Charles E. Binkley Give teachers high priority access to Covid-19 treatments and vaccines
First Opinion By Patrick Skerrett The ethics of pausing a vaccine trial in the midst of a pandemic: a conversation with Ruth Faden
First Opinion By Josephine Johnston The U.S. must do some heavy lifting to prepare for heritable genome editing
Health By Andrew Joseph Expert panel lays out guidelines for germline editing, while warning against pursuit of ‘CRISPR babies’
First Opinion By Jeffrey S. Flier Hospital CEOs, med school leaders shouldn’t sit on for-profit health care company boards
First Opinion By Alan Kadish and John Loike A pandemic ethical conundrum: Must health care workers risk their lives to treat Covid-19 patients?
Pharmalot By Ed Silverman A would-be chain of cancer centers wants to treat patients with Right to Try drugs, raising ethical questions
First Opinion By Parker Crutchfield, Tyler S. Gibb, and Michael Redinger To allocate remdesivir fairly, give it to communities that bear a disproportionate burden of Covid-19
Health Tech By Casey Ross At Mayo Clinic, sharing patient data with companies fuels AI innovation — and concerns about consent
Pharmalot By Ed Silverman Medical societies have ‘extensive’ financial ties with drug and device makers
First Opinion By Shailin A. Thomas and Arthur L. Caplan Are infertility treatments ‘essential’? How to ethically determine what kind of care must go on amid Covid-19
First Opinion By Eva Feder Kittay People with disabilities are at a disadvantage when scarce medical resources are being allocated
On the Front Lines By Eric Boodman Who gets the last ventilator? Facing the coronavirus, a hospital ponders the unthinkable